stoxline Quote Chart Rank Option Currency Glossary
  
Atrion Corporation (ATRI)
463.55  15.55 (3.47%)    03-28 16:00
Open: 454.88
High: 467.405
Volume: 29,162
  
Pre. Close: 448
Low: 453.86
Market Cap: 816(M)
Technical analysis
2024-03-28 4:49:50 PM
Short term     
Mid term     
Targets 6-month :  545.92 1-year :  637.64
Resists First :  467.4 Second :  545.92
Pivot price 436.08
Supports First :  389.57 Second :  341.45
MAs MA(5) :  442.36 MA(20) :  425.36
MA(100) :  357.48 MA(250) :  452.51
MACD MACD :  20.4 Signal :  19.6
%K %D K(14,3) :  89.7 D(3) :  84.2
RSI RSI(14): 67.8
52-week High :  670 Low :  274.98
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ ATRI ] has closed above the upper band by 16.9%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 41.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 467.45 - 469.08 469.08 - 470.57
Low: 439.63 - 441.68 441.68 - 443.56
Close: 460.21 - 463.15 463.15 - 465.84
Company Description

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and products for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

Headline News

Thu, 28 Mar 2024
Atrion (NASDAQ:ATRI) Sees Large Volume Increase - MarketBeat

Wed, 27 Mar 2024
Atrion (NASDAQ:ATRI) Shares Gap Up to $437.08 - MarketBeat

Mon, 25 Mar 2024
Some Investors May Be Worried About Atrion's (NASDAQ:ATRI) Returns On Capital - Yahoo Finance

Sat, 23 Mar 2024
Subdued Growth No Barrier To Atrion Corporation (NASDAQ:ATRI) With Shares Advancing 25% - Simply Wall St

Thu, 29 Feb 2024
Atrion: Q4 Earnings Snapshot - Houston Chronicle

Thu, 29 Feb 2024
Atrion Corp (ATRI) Faces Headwinds: Full Year Revenue and Net Income Decline - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Shares Out 2 (M)
Shares Float 1 (M)
Held by Insiders 22.8 (%)
Held by Institutions 66.4 (%)
Shares Short 66 (K)
Shares Short P.Month 67 (K)
Stock Financials
EPS 11
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 138
Profit Margin 11.4 %
Operating Margin 15.2 %
Return on Assets (ttm) 5.3 %
Return on Equity (ttm) 8 %
Qtrly Rev. Growth 1.7 %
Gross Profit (p.s.) 0
Sales Per Share 96.21
EBITDA (p.s.) 21.4
Qtrly Earnings Growth -22.4 %
Operating Cash Flow 20 (M)
Levered Free Cash Flow -12 (M)
Stock Valuations
PE Ratio 42.14
PEG Ratio 0
Price to Book value 3.35
Price to Sales 4.81
Price to Cash Flow 40.77
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android